1.Two Cases of Sequential Cutaneous Lymphomas in Immunocompromised Individuals Who Received Chemotherapies.
Korean Journal of Dermatology 2015;53(3):248-250
No abstract available.
Drug Therapy*
;
Lymphoma*
2.A Case of Majocchi Granuloma Caused by Microsporum canis Presented as Tinea Incognito.
Myong Il BAE ; Ki Heon JEONG ; Min Kyung SHIN ; Choong Rim HAW
Korean Journal of Dermatology 2015;53(9):735-737
No abstract available.
Granuloma*
;
Microsporum*
;
Tinea*
3.A Case Rhabdomyolysis by Rare Causes: After Consumption of Common Doses of Acetaminophen and Sauna.
Heung Jin KIM ; In Sang LEE ; Yeoung Hoon WHANG ; Yong Mock BAE ; Gil Dong SEO ; Myong June KIM ; Soo Heung KIM ; Il Doo KIM
Korean Journal of Nephrology 2000;19(1):153-157
A 21-year-young man had an episode of myalgia and chilling 3 days prior to hospital admission. He had consumed common doses of acetaminophen for one day, and was presented in the sauna room for an hour. On the next morning, he complained of dyspnea and was admitted. He presented in rhabdo-myolysis and acute renal failure with increased up-take in the proximal muscles by (99m)Tc-MPD bone scan. He was treated by hemodialysis and discharged on the twenty-eighth hospital day. Rhabdomyolysis has the variable causes. The causes of this case are two, the first cause is common doses of acetaminophen. But, there is no reports for rhabdomyolysis by common doses of acetaminophen only. However, we should consider that acetaminophen is a contributing factor in this case. The second cause is viral infection. Our patient had myalgia and chilling prior to hospital admission. Heat- stroke is well known cause of rhabdomyolysis. The mechnisms for rhabdomyolysis in this disease are hypovolemia, total body potassium deficit, and increased variable cytokines. Sauna, the last cause of our rhabdomyolysis case may have the same mechanisms with heatstroke. Our case had two causative factors, common doses of acetaminophen and sauna. These factors might be cooperated in our case of rhabdomyolysis and acute renal failure.
Acetaminophen*
;
Acute Kidney Injury
;
Cytokines
;
Dyspnea
;
Heat Stroke
;
Humans
;
Hypovolemia
;
Muscles
;
Myalgia
;
Potassium
;
Renal Dialysis
;
Rhabdomyolysis*
;
Steam Bath*
;
Stroke
4.Optimal Cut-off Value of PIVKA-II for Diagnosis of Hepatocellular Carcinoma: Using ROC Curve.
Myong Jin KIM ; Kang Woo BAE ; Pyoung Ju SEO ; In Kook JEONG ; Jung Hyuk KIM ; Bo Han LEE ; Ki Tae BANG ; Dong Woo KIM ; Il Han SONG
The Korean Journal of Hepatology 2006;12(3):404-411
BACKGROUND/AIMS: Protein induced by vitamin K absence or antagonist-II (PIVKA-II), also known as des-carboxyprothrombin (DCP), can be used as an alternative tool to alpha-fetoprotein (AFP) for surveillance of hepatocellular carcinoma (HCC). The aims of the present study were to compare PIVKA-II levels between the patients with HCC and patients with non-HCC chronic liver disease, to evaluate the correlation of PIVKA-II and AFP in HCC patients, and finally to estimate the optimal cut-off value for PIVKA-II for the diagnosis of HCC with using the receiver operating characteristic (ROC) curve. METHODS: A total of 227 consecutive patients with HCC (n=42) or chronic liver disease (n=185) were enrolled in this study. HCC was diagnosed histologically or by imaging such as computed tomography, magnetic resonance imaging or angiography. The serum PIVKA-II and AFP levels were measured by electrochemiluminoimmunoassay with using the Haicatch PIVKA-II kit and by immunoradiometric assay, respectively. RESULTS: The PIVKA-II level in the HCC patients was significantly higher than the non-HCC chronic liver disease patients (903.0+/-1156.7 vs. 111.7+/-211.0 mAU/ mL, respectively, P<0.01). PIVKA-II and AFP showed a statistical correlation in HCC patients (r=0.46, P<0.01). The sensitivity and specificity of PIVKA-II for the diagnosis of HCC were 66.7% and 74.1%, respectively, and when tasted together with AFP, the sensitivity was increased by 85.7%. For the ROC curve of PIVKA-II in HCC patients, the specificity of a 250 mAU/mL level of PIVKA-II was 95%. CONCLUSIONS: PIVKA-II was as useful surveillance tool for differentiating HCC from chronic liver disease, and a PIVKA-II value of 250 mAU/ mL was proposed as a significant cut-off value for diagnosis of hepatocellular carcinoma.
Adult
;
Aged
;
Biological Markers/*blood
;
Carcinoma, Hepatocellular/*diagnosis
;
Female
;
Humans
;
Liver Neoplasms/*diagnosis
;
Male
;
Middle Aged
;
Predictive Value of Tests
;
Protein Precursors/*blood
;
Prothrombin
;
ROC Curve
;
Tumor Markers, Biological/*blood
;
alpha-Fetoproteins/analysis
5.Two Granular Cell Tumors of the Colon with the Endosonographic Features.
Du San BAIK ; Jeong Eun SHIN ; Sang Soo LIM ; Se Young YUN ; Suk Bae KIM ; Hong Ja KIM ; Il Han SONG ; Na Hye MYONG
Korean Journal of Gastrointestinal Endoscopy 2010;40(4):280-284
Granular cell tumor is relatively uncommon, it is usually benign and it can be located anywhere throughout the body. It is uncommon in the digestive tract, and especially in the colon and rectum. The endosonographic features of granular cell tumor are usually a relatively hypoechoic, heterogenous lesion in the submucosa, but this tumor has rarely been reported in the colon. We report here on two cases of granular cell tumors of the colon that were observed by using endoscopic ultrasonograpy for making the differential diagnosis of a submucosal tumor and these tumors were confirmed by microscopic examinations after endoscopic mucosal resection.
Colon
;
Diagnosis, Differential
;
Gastrointestinal Tract
;
Granular Cell Tumor
;
Rectum
6.Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment
Hyo Seon RYU ; Hyun Jung KIM ; Woong Bae JI ; Byung Chang KIM ; Ji Hun KIM ; Sung Kyung MOON ; Sung Il KANG ; Han Deok KWAK ; Eun Sun KIM ; Chang Hyun KIM ; Tae Hyung KIM ; Gyoung Tae NOH ; Byung-Soo PARK ; Hyeung-Min PARK ; Jeong Mo BAE ; Jung Hoon BAE ; Ni Eun SEO ; Chang Hoon SONG ; Mi Sun AHN ; Jae Seon EO ; Young Chul YOON ; Joon-Kee YOON ; Kyung Ha LEE ; Kyung Hee LEE ; Kil-Yong LEE ; Myung Su LEE ; Sung Hak LEE ; Jong Min LEE ; Ji Eun LEE ; Han Hee LEE ; Myong Hoon IHN ; Je-Ho JANG ; Sun Kyung JEON ; Kum Ju CHAE ; Jin-Ho CHOI ; Dae Hee PYO ; Gi Won HA ; Kyung Su HAN ; Young Ki HONG ; Chang Won HONG ; Jung-Myun KWAK ;
Annals of Coloproctology 2024;40(2):89-113
Colorectal cancer is the third most common cancer in Korea and the third leading cause of death from cancer. Treatment outcomes for colon cancer are steadily improving due to national health screening programs with advances in diagnostic methods, surgical techniques, and therapeutic agents.. The Korea Colon Cancer Multidisciplinary (KCCM) Committee intends to provide professionals who treat colon cancer with the most up-to-date, evidence-based practice guidelines to improve outcomes and help them make decisions that reflect their patients’ values and preferences. These guidelines have been established by consensus reached by the KCCM Guideline Committee based on a systematic literature review and evidence synthesis and by considering the national health insurance system in real clinical practice settings. Each recommendation is presented with a recommendation strength and level of evidence based on the consensus of the committee.